nih
molecular
librari
screen
center
network
mlscn
subset
molecular
librari
initi
mli
compon
nih
roadmap
medic
research
consist
consortium
center
expertis
assay
develop
highthroughput
screen
ht
chemistri
informat
use
central
screen
librari
approxim
small
molecul
assay
research
commun
scientist
center
optim
assay
carri
highthroughput
screen
deposit
result
pubchem
vida
infra
base
data
assay
chemist
center
optim
initi
hit
order
develop
uniqu
small
molecul
probe
biolog
system
informaticist
contribut
data
handl
analysi
throughout
process
chemic
probe
develop
avail
research
public
privat
sector
via
data
deposit
pubchem
futur
via
access
sampl
synthet
protocol
prepar
probe
effort
support
ultim
goal
mlscn
mli
expand
avail
flexibl
use
smallmolecul
chemic
probe
basic
research
number
aspect
mlscn
make
initi
uniqu
academ
screen
center
well
screen
lead
optim
activ
undertaken
pharmaceut
biotechnolog
compani
first
research
public
privat
sector
access
screen
center
nih
fund
mechan
second
due
divers
sourc
assay
wide
expertis
avail
within
mslcn
specif
biolog
system
investig
screen
includ
high
risk
target
protein
biolog
system
whose
function
unknown
b
target
implic
orphan
diseas
diseas
typic
address
privat
sector
c
novel
uncommon
assay
system
eg
zebrafish
high
content
screen
nondrugg
target
inhibitor
aggreg
proteinprotein
interact
third
small
molecul
screen
librari
contain
structur
typic
found
commerci
collect
hous
pharmaceut
compani
sourc
uniqu
structur
includ
natur
product
novel
compound
librari
prepar
academ
investig
pilot
scale
librari
psl
grant
mechan
compound
gener
center
chemic
methodolog
librari
develop
cmld
vida
infra
obtain
solicit
nih
fourth
goal
mlscn
develop
select
chemic
probe
small
molecul
tool
interrog
novel
biochem
pathway
criteria
accept
class
molecul
broader
mlscn
involv
drug
discoveri
develop
therefor
chemic
probe
subject
constraint
physic
properti
function
group
metabol
profil
common
pharmaceut
industri
necessari
success
clinic
candid
exampl
compound
would
fit
definit
valuabl
chemic
probe
would
adher
commonli
prescrib
criteria
druglik
staurosporinederiv
ruthenium
complex
shown
select
subnanomolar
inhibitor
kinas
fifth
particularli
import
review
inclus
integr
medicin
chemistri
within
mlscn
center
allow
network
produc
chemic
probe
particular
properti
rather
simpli
identifi
appar
activ
screen
collect
final
unlik
screen
effort
industri
academia
data
avail
pubchem
delay
public
addit
ht
protocol
primari
screen
result
secondari
assay
data
profil
data
eg
aggreg
evalu
cytochrom
inhibit
spectroscop
profil
solubl
measur
followup
compound
librari
associ
biolog
data
synthet
protocol
access
nih
chemic
genom
center
ncgc
ultrahighthroughput
screen
uht
chemistri
center
appli
tool
small
molecul
screen
discoveri
develop
chemic
probe
studi
protein
cell
function
use
process
call
quantit
highthroughput
screen
qht
chemic
librari
screen
multipl
concentr
typic
seven
gener
concentrationrespons
curv
compound
cover
rang
five
order
magnitud
typic
nm
mm
qht
comprehens
effici
character
biolog
activ
larg
chemic
librari
yield
highqual
dataset
chemic
probe
develop
compound
profil
process
appli
success
cellfre
cellbas
assay
kalypsi
robot
system
use
multimod
detector
viewlux
envis
system
platebas
laser
cytometri
system
acumen
explor
highcapac
screen
reagentspar
plate
format
assay
detect
capabl
includ
absorb
luminesc
fluoresc
reson
energi
transfer
fret
timeresolv
fret
trfret
fluoresc
polar
fp
fluoresc
intens
fi
alphascreen
tm
well
cellbas
imag
assay
employ
fluoresc
protein
gfp
green
fluoresc
protein
ncgc
also
develop
new
paradigm
screen
informat
chemic
probe
develop
extend
applic
small
molecul
technolog
new
area
genom
collabor
academ
investig
worldwid
well
pharmaceut
biotechnolog
compani
produc
public
domain
data
therebi
allow
share
best
practic
enabl
chemic
genom
downstream
drug
develop
ncgc
accept
chemic
librari
screen
academ
industri
investig
produc
focus
librari
specif
project
ad
screen
collect
miniatur
qht
process
littl
mg
compound
support
sever
year
screen
hundr
divers
biolog
assay
ncgc
part
intramur
nih
program
nation
human
genom
research
institut
penn
center
molecular
discoveri
pcmd
approach
high
volum
screen
challeng
uniqu
capabl
key
technolog
center
abil
print
thousand
molecul
glass
surfac
size
busi
card
rapidli
test
molecul
proteas
enzym
purifi
human
anim
cell
bacteria
parasit
insect
virus
scientist
penn
center
also
abl
test
compound
thousand
miniatur
well
contain
millimeters
danio
rerio
zebrafish
unlik
organ
proven
worth
studi
heart
nerv
function
well
cancer
biolog
transpar
fish
easili
imag
pcmd
base
philadelphia
surround
local
ht
industri
lab
includ
merck
gsk
wyeth
johnson
johnson
industri
connect
help
transfer
ht
skill
univers
environ
center
emori
chemic
biolog
center
mlscn
capabl
adapt
optim
targetbas
phenotyp
assay
select
mlscn
identifi
proteinprotein
interact
small
molecul
probe
discoveri
center
theme
two
gener
screen
platform
establish
center
abl
perform
ht
high
content
screen
hc
use
varieti
vitro
biochem
assay
cell
report
assay
cell
phenotypebas
assay
particular
center
experienc
assay
monitor
proteinprotein
interact
enzym
activ
fluorescencebas
assay
includ
fi
fp
fret
exampl
assay
within
center
capac
includ
proteinprotein
interact
fi
fp
fret
alphascreen
tm
enzym
assay
fi
fp
coupl
assay
receptorligand
interact
assay
fi
fret
ca
imag
report
assay
luciferas
gfp
etc
viabil
assay
protein
transloc
assay
eg
receptor
intern
membran
nuclear
local
common
mlscn
center
overal
goal
pittsburgh
molecular
librari
screen
center
pmlsc
provid
scientif
commun
access
facil
design
optim
valid
implement
assay
ht
base
opticalbas
detect
method
identifi
chemic
probe
deposit
data
pubchem
databas
pmlsc
design
maximum
flexibl
regard
target
class
assay
format
develop
implement
cell
base
biochem
model
organ
danio
rerio
zebrafish
drosophila
melanogast
fli
assay
preferenti
plate
format
exist
opticalbas
detect
capabl
includ
autom
hc
imag
platform
absorb
fi
fp
timeresolv
fluoresc
trf
fret
luminesc
pmlsc
also
examin
structureact
relationship
activ
small
molecul
synthes
probe
molecul
demonstr
signific
potenc
target
select
southern
research
molecular
librari
screen
center
srmlsc
base
southern
research
institut
sri
anticanc
agent
discov
enter
clinic
trial
six
receiv
fda
approv
proceed
market
srmlsc
bring
extens
drug
discoveri
develop
expertis
network
especi
area
cancer
neurolog
diseasescn
disord
infecti
diseas
hiv
hepat
tb
emerg
pathogen
includ
influenza
avian
flu
west
nile
viru
sar
coronaviru
screen
center
broad
capabl
implement
cellular
molecular
targetbas
assay
includ
requir
contain
optim
miniatur
necessari
ht
facil
equip
stateoftheart
instrument
screen
plate
format
includ
two
orca
robot
rail
multipl
plate
reader
two
biomek
fx
liquid
handler
bioraptr
echo
nanolit
volum
dispens
addit
center
use
highspe
autom
evotec
opera
confoc
microscop
highthroughput
imag
assay
data
analysi
perform
scientist
expertis
molecular
model
predict
algorithm
qsar
analysi
use
robust
assort
chemoinformat
softwar
packag
san
diego
center
chemic
genom
sdccg
locat
biotechrich
heart
la
jolla
california
broad
expertis
biochemistri
abil
run
almost
assay
type
specif
biolog
theme
includ
target
involv
regul
cell
death
use
varieti
biochem
cellbas
assay
particular
emphasi
kinas
phosphatas
proteas
anoth
area
expertis
phenotyp
assay
stem
cell
differenti
use
fluoresc
report
two
main
technolog
theme
incorpor
sdccg
first
center
special
expertis
highthroughput
microscopi
tool
perform
highcont
cellbas
screen
cellular
phenotyp
drive
compound
select
unbias
manner
second
center
uniqu
across
network
capabl
perform
nmrbase
smallmolecul
screen
optim
nmrbase
method
except
valuabl
investig
molecular
target
easili
tractabl
method
proteinprotein
interact
protein
target
format
classic
ht
environ
scripp
research
institut
molecular
screen
center
span
scripp
campus
la
jolla
west
palm
beach
florida
scripp
brought
togeth
integr
combin
infrastructur
peopl
technolog
support
identif
proofofconcept
small
molecul
academ
set
small
molecul
compris
chemic
probe
adequ
potenc
select
physic
properti
stabil
show
robust
activ
cellbas
assay
vivo
allow
precompetit
advanc
field
break
biolog
center
equip
fulli
autom
kalypsi
screen
system
plate
hotel
incub
nl
ml
volum
dispens
aspir
pintool
head
compound
deliveri
uht
screen
larger
compound
deck
plate
reader
detector
includ
viewlux
ccdbase
plate
reader
envis
multimod
detector
equip
alpha
screen
tm
assay
format
includ
trf
fp
fi
fret
luminesc
absorb
center
vertic
integr
enterprisescal
data
manag
chemoinformat
high
throughput
lcm
compound
qualiti
assur
rodent
pharmacokinet
facil
downstream
synthet
followup
modular
librari
linear
chemic
approach
goal
scripp
center
rapid
collabor
public
interest
compound
advanc
understand
biolog
problem
illumin
new
nodal
control
point
physiolog
shortterm
chemic
perturb
strength
experi
mlscn
center
columbia
univers
cell
biolog
high
contenthighresolut
autom
cellular
imag
imag
analysi
phenotyp
assay
design
implement
main
imag
platform
center
incel
analyz
ge
healthcar
state
art
high
throughput
cell
imag
system
incel
instrument
use
three
laser
line
excit
krypton
laser
nm
argon
laser
nm
three
fluoresc
channel
record
three
independ
highspe
ccd
camera
emit
light
wavelength
rang
nm
captur
connect
kendro
plate
hotel
mitsubishi
robot
arm
system
imag
analyz
plate
well
without
supervis
depend
specif
assay
well
process
per
day
whole
array
differ
imag
analysi
modul
avail
analysi
perform
high
speed
fli
imag
system
enabl
center
screen
analyz
broad
varieti
assay
monitor
wide
spectrum
biolog
process
develop
innov
flow
cytometri
tool
discoveri
research
enabl
homogen
analysi
ligand
bind
proteinprotein
interact
high
throughput
sampl
handl
high
content
analysi
realtim
measur
cell
respons
use
novel
hypercyt
screen
technolog
virtual
molecular
assembl
cell
respons
display
ht
format
compat
flow
cytometri
assess
cellular
molecular
activ
small
molecul
possibl
moreov
creat
suspens
array
particl
assay
respons
highli
multiplex
perform
complex
cell
popul
without
loss
throughput
like
singl
compet
technolog
offer
versatil
flow
cytometri
mli
screen
potenti
avail
larg
number
laboratori
hous
flow
cytomet
worldwid
center
bring
togeth
expertis
span
biomed
biophys
chemic
comput
instrument
engin
disciplin
particularli
interest
enhanc
overal
discoveri
process
integr
physic
screen
comput
tool
includ
virtual
screen
chemoinformat
data
mine
goal
vanderbilt
screen
center
gprotein
coupl
receptor
gpcr
ion
channel
transport
enabl
investig
discov
develop
new
gener
small
molecul
probe
promot
understand
physiolog
diseas
process
particular
emphasi
structur
function
gpcr
ion
channel
transport
measur
biochem
cellular
cellfre
assay
made
use
wide
varieti
commerci
avail
novel
technolog
suit
detect
modal
includ
two
hamamatsu
fdss
kinet
imag
plate
reader
instrument
capabl
collect
data
well
plate
simultan
integr
reagent
addit
frame
per
second
wavelength
uv
far
red
dual
excit
emiss
fluoresc
polar
mode
fdss
also
support
ultra
lowlight
detect
aequorin
kineticflash
luminesc
format
addit
vanderbilt
center
support
highcont
screen
use
blueshift
isocyt
laser
scan
fluorimet
gener
twodimension
anisotropi
data
combin
capabl
pair
robust
autom
provid
tremend
flexibl
measur
action
test
compound
wide
rang
target
invest
infrastructur
combin
basic
industri
research
expertis
dedic
translat
chemic
biolog
establish
mainten
highli
collabor
environ
make
vanderbilt
center
well
suit
support
mlscn
pubchem
comprehens
publicli
access
databas
develop
nation
center
biotechnolog
inform
nation
librari
medicin
contain
inform
biolog
activ
small
molecul
march
pubchem
contain
million
record
million
uniqu
structur
data
assay
databas
link
entrez
databas
pubm
pubchem
central
data
eg
assay
result
secondari
assay
structur
compound
synthes
gener
within
mlscn
deposit
pubchem
access
rang
data
larg
librari
divers
compound
enorm
potenti
use
informat
commun
develop
comput
model
pharmacophor
model
algorithm
predict
biolog
activ
properti
small
molecul
two
distinct
aspect
mslcn
requir
particip
input
chemist
first
synthet
chemistri
sourc
compound
within
screen
librari
therefor
assay
hit
second
expertis
synthet
medicin
chemistri
requir
optim
hit
usabl
probe
biolog
system
screen
center
medicin
synthet
chemistri
expertis
order
optim
hit
identifi
ht
campaign
develop
chemic
probe
specif
capabl
vari
howev
typic
strategi
employ
includ
parallel
synthesi
comput
informat
analysi
analyt
capabl
lcm
techniqu
structur
novel
compound
prepar
synthet
protocol
analyt
data
biolog
data
avail
sampl
final
probe
develop
deposit
mlsmr
work
group
compris
chemist
center
meet
regularli
share
inform
best
practic
insur
optim
use
resourc
anoth
key
compon
molecular
librari
initi
develop
novel
technolog
gener
chemic
divers
applic
pittsburgh
molecular
librari
screen
center
report
identif
sid
inhibitor
mitogenactiv
protein
kinas
phosphatas
initi
hit
exhibit
modest
potenc
ic
mm
howev
appear
display
select
phosphatas
excel
select
target
test
small
librari
compound
design
prepar
effort
identifi
compound
improv
potenc
toward
end
sever
new
uracilbas
compound
sid
exhibit
improv
potenc
dualspecif
phosphatas
involv
number
process
relat
cell
prolifer
avail
potent
select
cell
permeabl
probe
would
help
enabl
thorough
understand
role
enzym
play
cell
cycl
signal
transduct
oncogenesi
apoptosi
small
molecul
inhibitor
previous
report
hamper
low
vitro
potenc
lack
cellular
activ
poor
select
uracil
quinolin
pmlsc
repres
novel
structur
class
base
promis
physicochem
properti
may
provid
improv
inhibitor
previous
report
famili
protein
play
crucial
role
tissu
homeostasi
apoptosi
program
cell
death
domain
death
agonist
bid
proapoptot
member
famili
promot
cell
death
activ
cleav
bid
truncat
activ
form
tbid
nmrbase
screen
librari
compos
fragment
follow
sar
optim
interligand
noe
led
identif
two
chemic
fragment
bind
surfac
bid
coval
linkag
two
fragment
provid
highaffin
bident
deriv
vitro
cellular
assay
show
compound
prevent
tbid
transloc
mitochondri
membran
subsequ
releas
proapoptot
stimuli
inhibit
neuron
apoptosi
low
micromolar
rang
compound
may
lead
therapeut
agent
potenti
treat
disord
associ
bid
activ
includ
neurodegen
diseas
cerebr
ischemia
brain
trauma
screen
compound
mlsmr
scientist
pcmd
inhibitor
cathepsin
b
result
identif
character
altern
substrat
sid
studi
also
describ
issu
relat
nucleophil
dithiothreitol
dtt
cystein
reduct
frequent
use
ht
protocol
potenti
reactiv
electrophil
site
probe
molecul
develop
quantit
highthroughput
screen
qht
paradigm
provid
concentrationrespons
curv
larg
chemic
librari
singl
experi
major
focu
nih
chemic
genom
center
strategi
appli
screen
inhibitor
enzym
pyruv
kinas
allow
sar
develop
directli
primari
screen
data
rapid
analysi
triag
activ
cluster
analysi
class
cyanooxazol
inhibitor
exemplifi
sid
identifi
exhibit
activ
nanomolar
rang
ac
nm
importantli
structur
relat
analog
exhibit
rang
potenc
nanomolar
inact
rang
activ
also
identifi
ht
experi
sid
activ
pyruv
kinas
ac
concentr
nm
gaucher
diseas
inherit
disord
character
defici
glucocerebrosidas
activ
assay
identifi
small
molecul
inhibitor
glucocerebrosidas
develop
three
probe
identifi
identifi
test
seri
purchas
analog
initi
hit
sid
sid
member
initi
screen
librari
sever
probe
shown
restor
glucocerebrosidas
activ
cultur
cell
gaucher
patient
result
consist
correct
traffick
misfold
glucocerebrosidas
antagonist
probe
scripp
sphingosin
regul
vascular
barrier
lymphoid
develop
well
lymphocyt
egress
lymphoid
organ
activ
highaffin
receptor
base
phosphat
ester
structur
x
revers
antagonist
x
ch
design
provid
nonreact
chemic
probe
vivo
activ
compound
use
gain
mechanist
insight
system
organ
access
genet
manipul
investig
potenti
therapeut
modul
vascular
airway
administr
prefer
r
enantiom
compound
induc
loss
capillari
integr
mous
skin
lung
affect
number
constitut
blood
lymphocyt
instead
alter
lymphocyt
traffick
phenotyp
requir
supraphysiolog
elev
tone
revers
antagonist
vivo
twophoton
imag
lymph
node
confirm
requir
oblig
agon
data
consist
presenc
stromal
barrier
mechan
gate
lymphocyt
egress
chemic
modul
reveal
differ
set
point
among
tissu
highlight
mechanist
advantag
lymphocyt
sequestr
risk
pulmonari
edema
therapeut
intervent
research
srmlsc
recent
develop
ht
allow
identif
potenti
inhibitor
sever
acut
respiratori
syndrom
coronaviru
sar
cov
larg
compound
librari
luminescentbas
assay
measur
inhibit
sar
covinduc
cytopath
effect
cpe
vero
cell
valid
two
differ
divers
set
compound
sar
cov
hit
rate
librari
approxim
valid
ht
assay
employ
screen
librari
sar
cov
hit
rate
librari
singledos
format
determin
approxim
screen
three
librari
result
identif
sever
novel
compound
effect
inhibit
cpe
sar
cov
vitro
three
hit
compound
shown
identifi
promis
lead
candid
evalu
team
srmlsc
also
recent
develop
screen
pantothen
synthetas
ps
ps
ec
encod
panc
gene
catalyz
essenti
adenosin
triphosph
atp
depend
condens
dpantoat
balanin
form
pantothen
bacteria
yeast
plant
pantothen
key
precursor
biosynthesi
coenzym
coa
acyl
carrier
protein
acp
enzym
absent
mammal
coa
acp
essenti
cofactor
bacteri
growth
ps
attract
chemotherapeut
target
autom
highthroughput
screen
develop
identifi
drug
inhibit
mycobacterium
tuberculosi
ps
activ
ps
measur
spectrophotometr
enzymat
cascad
involv
myokinas
pyruv
kinas
lactat
dehydrogenas
rate
ps
atp
util
quantit
reduct
absorb
due
oxid
nadh
nad
lactat
dehydrogenas
allow
intern
control
detect
interfer
compound
absorb
nm
coupl
enzymat
reaction
use
screen
compound
format
led
discoveri
novel
inhibitor
ps
exhibit
potenti
antimicrobi
agent
antagonist
new
mexico
mlsc
research
new
mexico
mlsc
use
combin
virtual
biomolecular
screen
discov
select
agonist
estrogen
hormon
critic
develop
normal
physiolog
pathophysiolog
numer
human
tissu
effect
estrogen
tradit
sole
ascrib
estrogen
receptor
era
recent
erb
member
solubl
nuclear
ligandactiv
famili
transcript
factor
howev
recent
shown
bind
estrogen
high
affin
resid
endoplasm
reticulum
activ
multipl
intracellular
signal
pathway
differenti
function
era
erb
new
mexico
mlsc
team
use
combin
virtual
biomolecular
screen
isol
compound
select
bind
studi
led
identif
first
agonist
shown
capabl
activ
complex
environ
classic
new
estrogen
receptor
complet
human
genom
project
coordin
effort
govern
academia
industri
prompt
vast
expans
medic
research
focus
understand
fundament
caus
human
diseas
molecular
librari
imag
initi
natur
extens
groundbreak
effort
provid
access
assay
ht
capabl
small
molecul
librari
chemic
optim
expertis
novel
chemic
probe
develop
allow
studi
gene
function
biochem
pathway
cellular
biolog
also
possibl
initi
start
point
new
drug
particularli
rare
diseas
identifi
data
deposit
pubchem
via
effort
also
serv
unpreced
sourc
inform
scientist
biomed
disciplin
avail
larg
dataset
biolog
activ
common
set
compound
serv
stimul
advanc
comput
predict
model
biolog
activ
chemic
properti
dataset
also
expedit
biomed
research
use
evalu
select
toxic
offtarget
activ
compound
valu
success
initi
may
obviou
measur
number
year
adopt
technolog
approach
eg
ht
hit
optim
typic
avail
insid
pharmaceut
industri
provid
train
opportun
inspir
wider
scientif
commun
